Ann: Oncolytic Virotherapy CF33 Patent Granted in Japan, page-60

Hi All

Like most investors, I get lazy. Mrs OOO will vouch for that.

For months now, I have not bothered reading the boilerplate, 'About Imugene', that is tacked on to the bottom of every announcement. I read it today. One poster highlighted the second sentence in the paragraph that piqued my interest ... I am much more focused on the first sentence:

Together with leading specialists and medical professionals, we believe Imugene’s immuno-oncology therapies will become foundation treatments for cancer. Our goal is to ensure that Imugene and its shareholders are at the forefront of this rapidly growing global market.

Foundation treatments for cancer! Read it slowly.

This is leading specialists asserting that the base of any cancer drug treatment will be provided by Imugene products. That is, our drugs will underpin all other treatments: It will be a case of Imugene+Other Drug=Treatment.

So forget 'the market for this' and 'the market for that' and focus on The Market For Everything.

Then focus on the IMU shares you own.

Then focus on getting more. I am.

OOO